Test Price
2,800 AED✅ Home Collection Available
CCT5 Gene Neuropathy (Hereditary Sensory Neuropathy with Spastic Paraplegia) Genetic Test in UAE – DHA-Accredited NGS
Executive Summary & Core Metrics
- Accuracy: >99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139).
- Logistics: VIP Mobile Phlebotomy & temperature-controlled cold-chain home collection available daily 8 AM – 11 PM.
- Clinical Guidance: Complimentary telephonic post-test genetic counselling and result interpretation included.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This Next-Generation Sequencing (NGS) test comprehensively analyzes the full coding region of the CCT5 gene to identify pathogenic variants linked to hereditary sensory neuropathy with spastic paraplegia, a progressive neurogenetic disorder. The test is performed on an Illumina platform with >99% coverage and variant-level resolution.
| Feature | Our Test (DHA‑Accredited NGS) | Closest Alternative (Sanger Sequencing of Single Exons) |
|---|---|---|
| Precision | >99% coverage of entire CCT5 coding region; variant‑level resolution | Targeted regions only; may miss deep intronic or copy‑number changes |
| Method | NGS (Next‑Generation Sequencing) on Illumina platform, clinically validated | Sanger Sequencing, limited to pre‑defined exons |
| Turnaround | 3 to 4 weeks (comprehensive analysis & clinical report) | 4–6 weeks for multiple exons; non‑comprehensive |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist, I understand the anxiety that accompanies hereditary neuropathies. This NGS test delivers the molecular clarity required for precise treatment planning, familial risk assessment, and future medical management. I strongly advise that results be correlated with the full clinical picture and post-test genetic counselling.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Patient Safety Advisory
Do not discontinue prescribed medication without consulting your doctor. This test is for diagnostic confirmation and does not replace clinical management.
Exclusion Criteria & Emergency Red Flags
- Exclusion: If you have an active infection or are unable to provide a blood sample, contact our team to reschedule.
- Exclusion: This test is not intended for asymptomatic minors without explicit consent under UAE Child Rights Law (Wadeema’s Law) and relevant federal regulations; a paediatric clinical geneticist must be involved.
- ER Red Flag: If you experience sudden worsening of spasticity, loss of bladder control, or acute sensory loss, seek emergency care immediately.
Patient FAQ & Clinical Guidance
1. What is the CCT5 gene neuropathy NGS test?
This NGS test analyzes the entire CCT5 gene to detect mutations causing hereditary sensory neuropathy with spastic paraplegia.
2. Who should consider undergoing this genetic test?
Patients with unexplained sensory neuropathy and spastic paraplegia, especially those with a family history of similar conditions, should consider this test. Pre- and post-test genetic counselling is recommended.
3. What are the sample requirements and turnaround time?
A single peripheral blood sample (whole blood, DNA, or FTA card) is collected via our VIP Mobile Phlebotomy service. Results are available within 3 to 4 weeks.
4. How is my genetic data protected?
All genetic data is handled in strict compliance with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning Health ICT. Your data is encrypted, anonymized, and never shared without explicit consent.
UAE Regulatory & Data Privacy Adherence
Your Privacy and Rights
This test is conducted under the regulatory oversight of the Dubai Health Authority (DHA) and complies with UAE Federal Decree-Law No. 45 of 2021 (PDPL) and Federal Law No. 2 of 2019 on Health ICT. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | CCT5 Gene Neuropathy (Hereditary Sensory with Spastic Paraplegia) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Peripheral whole blood, DNA, or FTA card |
| Methodology Used | Next-Generation Sequencing (NGS) – Illumina platform |
| ICD-10-CM Code | G60.8 |
| LOINC Code | 91553-4 |
| DHA Facility License & Laboratory Address | License Number: 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians